LONGER-TERM (UP to 6 YEARS) EFFICACY of OFATUMUMAB in PEOPLE with RECENTLY DIAGNOSED and TREATMENT-NAIVE RELAPSING MULTIPLE SCLEROSIS

Authors
Category Primary study
Conference54th Annual Conference of the Italian Society of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: 0ca42d3069e2a46d1832fdd20d52f01b9bc0d3bd
First added on: Jan 10, 2026